Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

@article{Fischer2017OutcomeOM,
  title={Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.},
  author={Stefanie Fischer and Torgrim Tandstad and Matthew J Wheater and Emilio Porfiri and Aude Fl{\'e}chon and J Aparicio and Dirk Klingbiel and Breda Skrbinc and Umberto Basso and Jonathan Shamash and Anja Lorch and Klaus-Peter Dieckmann and Gabriella Cohn-Cedermark and Olof St{\aa}hl and Caroline Chau and E Arriola and Kalena Marti and P. G. Hutton and Brigitte Laguerre and Pablo Maroto and J{\"o}rg Beyer and Silke Gillessen},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2017},
  volume={35 2},
  pages={194-200}
}
Purpose Adjuvant carboplatin is one of three management strategies that may follow inguinal orchiectomy in clinical stage I seminoma. However, little is known about the outcome of patients who experience a relapse after such treatment. Patients and Methods Data from 185 patients who relapsed after adjuvant carboplatin between January 1987 and August 2013 at… CONTINUE READING